Evidence-Based Guidance for the Management of Immune-Related Adverse Events: Resources for Clinicians

Get expert insights on how the latest clinical data inform identification and management of challenging immune-related adverse events in patients with cancer who are receiving immune checkpoint inhibitors.

John A. Thompson, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Released: May 7, 2019 Expired: No longer available for credit

Use this interactive tool to easily access NCCN Guidelines on management of irAEs for your specific patient scenarios.

John A. Thompson, MD Released: February 7, 2019

Checkpoint inhibitors come with a unique array of immune-related adverse events, which nurses can struggle to manage effectively and which concern patients. Read my thoughts on managing these adverse events and discussing them with patients.

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP Released: March 19, 2019

In this downloadable slideset, review expert insights and recommendations from NCCN Guidelines on identification and management of immune-related adverse events associated with immune checkpoint inhibitor therapy.

John A. Thompson, MD Released: May 7, 2019